A carregar...

5PSQ-010 Efficacy and safety of agalsidase alfa in fabry disease

BACKGROUND: Fabry disease is included within the lipid deposition diseases that occur due to mutations in the gene that encodes the α-galactosidase enzyme. As a consequence, a fatty substance, globotriosilceramide (GL-3), is responsible for the illness of different organs such as the heart, eyes or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Hosp Pharm
Main Authors: Rosa, V González, Gil, E Atienza, Torres, MI Sierra, Rascón, M Zaragoza, Alonso, M Pajares
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535223/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.364
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!